ストックスクリーナーアプリを入手
14.93
0.40%
0.06
前日終値:
$14.87
開ける：
$14.85
24時間の取引高:
437.25K
Relative Volume:
0.96
時価総額：
$5.32B
収益：
$5.21B
当期純損益:
$-211.00M
株価収益率:
-24.16
EPS:
-0.6179
ネットキャッシュフロー:
$861.30K
1週間 パフォーマンス:
-0.47%
1か月 パフォーマンス:
-6.22%
6か月 パフォーマンス:
-11.76%
1年 パフォーマンス:
+27.28%
1日の値動き範囲:
$14.76
$15.11
1週間の範囲:
$14.65
$15.21
52週間の値動き範囲:
$11.63
$18.91
Bausch Lomb Corp Stock (BLCO) Company Profile
Compare BLCO vs ISRG, BDX, ALC, MDLN, RMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BLCO
Bausch Lomb Corp
|
14.93 | 5.30B | 5.21B | -211.00M | 861.30K | -0.6179 |
ISRG
Intuitive Surgical Inc
|
402.95 | 144.07B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
140.71 | 39.67B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
65.18 | 31.54B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
34.71 | 30.39B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
188.45 | 27.36B | 5.54B | 1.52B | 1.74B | 10.37 |
Bausch Lomb Corp Stock (BLCO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-05 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2025-12-11 | アップグレード | Citigroup | Neutral → Buy |
| 2025-12-02 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2025-10-01 | 開始されました | Goldman | Neutral |
| 2025-05-02 | 繰り返されました | H.C. Wainwright | Buy |
| 2025-03-28 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2024-12-11 | ダウングレード | Citigroup | Buy → Neutral |
| 2024-12-02 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2024-10-15 | アップグレード | Evercore ISI | In-line → Outperform |
| 2024-07-10 | 開始されました | Raymond James | Outperform |
| 2024-05-06 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2024-01-04 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2023-12-12 | 開始されました | Stifel | Hold |
| 2023-10-03 | 再開されました | Evercore ISI | Outperform |
| 2023-05-30 | 再開されました | Morgan Stanley | Equal-Weight |
| 2023-03-09 | 開始されました | Needham | Hold |
| 2022-12-21 | 開始されました | Barclays | Equal Weight |
| 2022-09-12 | 開始されました | H.C. Wainwright | Buy |
| 2022-07-26 | 開始されました | RBC Capital Mkts | Outperform |
| 2022-06-24 | 開始されました | Evercore ISI | Outperform |
| 2022-06-06 | 開始されました | Citigroup | Buy |
| 2022-05-31 | 開始されました | Deutsche Bank | Hold |
| 2022-05-31 | 開始されました | Goldman | Neutral |
| 2022-05-31 | 開始されました | Guggenheim | Buy |
| 2022-05-31 | 開始されました | JP Morgan | Neutral |
| 2022-05-31 | 開始されました | Jefferies | Buy |
| 2022-05-31 | 開始されました | Morgan Stanley | Equal-Weight |
| 2022-05-31 | 開始されました | Wells Fargo | Overweight |
| 2022-05-11 | 開始されました | Cowen | Outperform |
すべてを表示
Bausch Lomb Corp (BLCO) 最新ニュース
Bausch + Lomb Corp (BLCO) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Bausch + Lomb Corp (BLCO) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Bausch + Lomb Corp (BLCO) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Bausch + Lomb Corp (BLCO) Institutional Confidence - TradingKey
Bausch + Lomb Corp (BLCO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Bausch + Lomb Corp (BLCO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Bausch + Lomb Corp (BLCO) Valuation: PE, PB & Fair Value Analysis - TradingKey
Bausch + Lomb Corp (BLCO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Bausch + Lomb Corp (BLCO) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Bausch & Lomb (NYSE: BLCO) executive has 1,008 shares withheld for tax on RSU vesting - Stock Titan
Emmetrope Ophthalmics LLC announced that it has received funding from Bausch + Lomb Corporation - marketscreener.com
Bausch + Lomb Corporation (BLCO): Investor Outlook With An 18.53% Potential Upside - DirectorsTalk Interviews
Bausch + Lomb to lay off employees in Missouri - Yahoo Finance
Transcript : Bausch + Lomb Corporation Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-09-2026 01 - marketscreener.com
Bausch + Lomb Dry Eye Launch Highlights Valuation Gap And Growth Questions - Yahoo Finance
Why Bausch + Lomb Corp stock is sliding today - Wealth Awesome
Bausch + Lomb Corporation (BLCO): Investor Outlook and Potential 15.62% Upside in the Healthcare Sector - DirectorsTalk Interviews
Assessing Bausch + Lomb (NYSE:BLCO) Valuation After Blink Triple Care Preservative Free U.S. Launch - Sahm
Will Blink Triple Care’s Preservative Free Launch Reshape Bausch + Lomb’s (BLCO) Consumer Eye Care Narrative? - webull.com
Bausch + Lomb’s New Dry Eye Launch And What It Means For BLCO - Sahm
RBC Capital reiterates Bausch & Lomb stock rating at Outperform By Investing.com - Investing.com Australia
RBC Capital reiterates Bausch & Lomb stock rating at Outperform - Investing.com
Bausch + Lomb Corp stock (CA07174N1090): valuation metrics in focus after recent trading in Toronto - AD HOC NEWS
Bausch + Lomb Insiders Added US$2.46m Of Stock To Their Holdings - Moomoo
Liquidity Mapping Around (BLCO) Price Events - Stock Traders Daily
Bausch + Lomb (BLCO) R&D Day 2026 Summary - Quartr
BLCO.CA Stock Price, Quote & Chart | BAUSCH + LOMB CORP (TSX:BLCO) - ChartMill
Bausch + Lomb launches preservative-free dry eye drops in U.S. By Investing.com - Investing.com South Africa
Bausch + Lomb Launches Blink® Triple Care Preservative Free Lubricant Eye Drops in the United States - BioSpace
Preservative-free eye drops offer up to 10 hours dry-eye relief - Stock Titan
Bausch + Lomb Corporation (BLCO) Investor Outlook: Analyzing Growth Potential with a 14% Upside - DirectorsTalk Interviews
BLCO Stock Price, Quote & Chart | BAUSCH + LOMB CORP (NYSE:BLCO) - ChartMill
Bausch & Lomb (BLCO) director awarded 15,842 RSUs under 2022 Omnibus Incentive Plan - Stock Titan
Bausch & Lomb (NYSE: BLCO) grants 15,842 RSUs to director - Stock Titan
Bausch & Lomb (NYSE: BLCO) director awarded 15,842-share RSU grant - Stock Titan
Bausch & Lomb (BLCO) director John Paulson receives 15,842-share RSU grant - Stock Titan
Bausch & Lomb (BLCO) director Karen Ling awarded 15,842 RSUs as annual equity grant - Stock Titan
Director at Bausch & Lomb (NYSE: BLCO) gets 15,842-share RSU award - Stock Titan
Bausch & Lomb Corp (BLCO) awards 15,842 RSUs to director Collis - Stock Titan
Bausch & Lomb (BLCO) director granted 15,842 RSUs in annual equity award - Stock Titan
Bausch & Lomb (NYSE: BLCO) director receives 15,842-share RSU grant - Stock Titan
Bausch + Lomb Lifts 2026 Guidance, 1Q Loss Narrows - Moomoo
Bausch & Lomb (NYSE: BLCO) CEO reports 2,886-share tax withholding on RSU vesting - Stock Titan
Bausch + Lomb: Even Though Growth Continues, I Don't See A Way Higher (NYSE:BLCO) - Seeking Alpha
Evercore ISI Group Maintains Bausch + Lomb (BLCO) Outperform Recommendation - MSN
Bausch + Lomb Corporation (BLCO) Stock Analysis: Unpacking a Potential 13% Upside for Investors - DirectorsTalk Interviews
Brent Saunders: Healthcare Innovation Leader, Global Pharmaceutical Executive, and Bausch + Lomb CEO - BBN Times
Bausch + Lomb to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference - BioSpace
Medical Devices & SuppliesSpecialty Stocks Q1 Teardown: Bausch + Lomb (NYSE:BLCO) Vs The Rest - Yahoo Finance
Bausch + Lomb Corporation - Baystreet.ca
Bausch + Lomb CEO, R&D chief to join Goldman Sachs health-care chat - Stock Titan
Bausch Lomb Corp (BLCO) 財務データ
収益
当期純利益
現金流量
EPS
1.16%
0.54%
大文字化:
|
ボリューム (24 時間):